Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 252-258

  Mines, Marjelo A ^a   Beurel, Eleonore ^a   Jope, Richard S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Attention deficit hyperactivity disorder; Glycogen synthase kinase 3; Methylphenidate; Pre pulse inhibition

Indexed keywords

AMPHETAMINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; METHYLPHENIDATE;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; KNOCKOUT MOUSE; LOCOMOTOR HYPERACTIVITY; MALE; MOUSE; NONHUMAN; OPEN FIELD ACTIVITY; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOGEN SYNTHASE KINASE 3; HYPERKINESIS; INHIBITION (PSYCHOLOGY); LITHIUM; MALE; METHYLPHENIDATE; MICE; MICE, INBRED C57BL; SENSORY GATING; TIME FACTORS;

EID: 84871921802     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.10.018     Document Type: Article

References (37)

1. Y. Ago, T. Tanaka, Y. Kita, H. Tokumoto, K. Takuma, and T. Matsuda Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release Neuropharmacol 62 2012 1634 1639
2. M. Beaulieu, E. Tirotta, T.D. Sotnikova, B. Masri, A. Salahpour, R.R. Gainetdinov, E. Borrelli, and M.G. Caron Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo J. Neurosci. 27 2007 881 885 (Pubitemid 46174508)
3. J.M. Beaulieu, T.D. Sotnikova, R.R. Gainetdinov, and M.G. Caron Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice J. Biol. Chem. 281 2006 32072 32080 (Pubitemid 46036761)
4. J.M. Beaulieu, T.D. Sotnikova, W.D. Yao, L. Kockeritz, J.R. Woodgett, R.R. Gainetdinov, and M.G. Caron Lithium anatagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc. Nat. Acad. Sci., U.S.A 101 2004 5099 5104 (Pubitemid 38469209)
5. D.P. Cantwell Attention deficit disorder: a review of the past 10 years J. Am. Acad. Child Adolesc. Psychiatry 35 1996 978 987 (Pubitemid 26266328)
6. Center for Disease Control, 2010. Increasing Prevalence of Parent-Reported Attention-Deficit/Hyperactivity Disorder Among Children - United States, 2003 and 2007. Morbidity and Mortality Weekly Report 59, 1439-1443.
7. P. De Sarno, X. Li, and R.S. Jope Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium Neuropharmacol 43 2002 1158 1164 (Pubitemid 36009369)
8. B.W. Doble, and J.R. Woddgett GSK-3: tricks of the trade for a multi-tasking kinase J. Cell Sci. 116 2003 1175 1186 (Pubitemid 36410657)
9. T.Y. Eom, and R.S. Jope Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3α/β impairs in vivo neural precursor cell proliferation Biol. Psychiatry 66 2009 494 502
10. D.G. Flood, E. Zuvich, M.J. Marino, and M. Gasior The effects of d-amphetamine, methylphenidate, syndocarb, and caffeine on pre-pulse inhibition of the startle reflex in DBA/2 mice Psychopharmacol 211 2010 325 336
11. T. Force, and J.R. Woodgett Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development J. Biol. Chem. 284 2009 9643 9647
12. S.J. Gatley, D. Pan, R. Chen, G. Chaturvedi, and Y.S. Ding Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters Life Sci. 58 1996 231 239 (Pubitemid 126352709)
13. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of pre-pulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Neuropsychopharmacol 156 2001 117 154 (Pubitemid 32702206)
14. T.D. Gould, H. Einat, R. Bhat, and H.K. Manji AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test Int. J. Neuropsychopharmacol. 7 2004 387 390 (Pubitemid 39648068)
15. R.S. Jope, and G.B.W. Johnson The glamour and gloom of glycogen synthase kinase-3 (GSK3) Trends Biochem. Sci. 29 2004 95 102 (Pubitemid 38186580)
16. U.G. Kang, M.S. Seo, M.S. Roh, Y. Kim, S.C. Yoon, and Y.S. Kim The effects of clozapine on the GSK-3-mediated signaling pathway FEBS Lett. 560 2004 115 119 (Pubitemid 38264303)
17. R. Kuczenski, and D.S. Segal Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine J. Neurosci. 16 2002 7264 7271
18. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J. Neurochem. 68 1997 2032 2037 (Pubitemid 27176139)
19. X. Li, K.M. Rosborough, A.B. Friedman, W. Zhu, and K.A. Roth Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics Int. J. Neuropsychopharmacol. 10 2006 7 19
20. M.H. Liang, and D.M. Chuang Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival J. Biol. Chem. 282 2007 3904 3917
21. E.J. McManus, K. Sakamoto, L.J. Armit, L. Ronaldson, N. Shpiro, R. Marquez, and D.R. Alessi Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis EMBO J. 24 2005 1571 1583 (Pubitemid 40646447)
22. J.S. Miller, R.J. Tallarida, and E.M. Unterwald Cocaine-induced hyperactivity and sensitization are dependent on GSK3 Neuropharmacol 56 2009 1116 1123
23. M.A. Mines, and R.S. Jope Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice Cell Signal 24 2012 1398 1405
24. E.J. Nestler, S.E. Hyman, and R.C. Malenka Molecular Neuropharmacology: a foundation for Clinical Neuroscience first ed. 2001 The McGraw-Hill Companies New York
25. M. Olfson, M.J. Gameroff, S.C. Marcus, and P.S. Jensen National trends in the treatment of attention deficit hyperactivity disorder Am. J. Psychiatry 160 2003 1071 1077 (Pubitemid 41070965)
26. J.C. Ong, S.A. Brody, C.H. Large, and M.A. Geyer An investigation of the efficacy of mood stabilizers in rodent models of pre-pulse inhibition J. Pharmacol. Exp. Ther. 315 2005 1163 1171 (Pubitemid 41635404)
27. H.J. Park, F.J. Cui, J.Y. Hwang, and U.G. Kang Effects of clozapine on behavioral sensitization induced by cocaine Psychiatry Res. 175 2010 165 170
28. A. Polter, E. Beurel, S. Yang, R. Garner, L. Song, C.A. Miller, J.D. Sweatt, L. McMahon, A.A. Bartolucci, X. Li, and R.S. Jope Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances Neuropsychopharmacol 8 2010 1761 1774
29. J. Prickaerts, D. Moerchars, K. Cryns, I. Lanaerts, H. van Craenndonk, I. Goris, G. Daneels, J.A. Bouwknecht, and T. Steckler Transgenic mice over-expressing glycogen synthase kinase β: a putative model of hyperactivity and mania J. Neurosci. 26 2006 9022 9029 (Pubitemid 44319393)
30. M.V. Solanto Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research Behav. Brain Res. 130 2002 65 71 (Pubitemid 34195322)
31. D. Sulzer, T.K. Chen, Y.Y. Lau, H. Kristensen, S. Rayport, and A. Ewing Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J. Neurosci. 15 1995 4102 4108
32. N.R. Swerdlow, M. Weber, Y. Qu, G.A. Light, and D.L. Braff Realistic expectations of pre-pulse inhibition in translational models for schizophrenia research Psychopharmacology 199 2008 331 388
33. A.H. Tang, S.R. Fanklin, C.S. Himes, M.W. Smith, and R.E. Tenbrink PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties J. Pharmacol. Exp. Ther. 281 1997 440 447 (Pubitemid 27203099)
34. K. Umeda, K. Suemaru, N. Todo, N. Egashira, K. Mishima, K. Iwasaki, M. Fujiwara, and H. Araki Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice Eur. J. Pharmacol. 553 2006 157 162 (Pubitemid 44779598)
35. I.D. Waldman, D.C. Rowe, A. Abramowitz, S.T. Kozel, J.H. Mohr, S.L. Sherman, H.H. Cleveland, M.L. Sanders, J.M. Gard, and C. Stever Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity Am. J. Hum. Genet. 63 1998 1767 1776 (Pubitemid 30415740)
36. C. Xu, J. Wang, P. Wu, Y. Xue, W. Zhu, Q. Li, H. Zhai, J. Shi, and L. Lu Glycogen synthase kinase 3β in the nucleus accumbens core is critical for methamphetamine-induced behavioral sensitization J. Neurochem. 118 2011 126 139
37. C.J. Yuskaitis, M.A. Mines, M.K. King, J.C. Sweatt, C.A. Miller, and R.S. Jope Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome Biochem. Pharmacol. 79 2010 632 646